RNS Announcements
9Final Issue of RiverFort Subscription Shares
the Company to RiverFort Global Opportunities PCC Ltd (the " Riverfort Shares "), in accordance with the terms of the Facility announced on 3 August 2023 (the " Riverfort Facility "). The issuance of the Riverfort Shares will settle the full outstanding balance on the Riverfort Facility. As noted in Sareum's announcement of 28 March 2024, the Company does not intend to make any further withdrawals pursuant to the Riverfort Facility and accordingly the Company will not be issuing any further Subscription Shares pursuant to the Riverfort Facility. Admission and Total Voting Rights …
Issue of RiverFort Subscription Shares
the Company to RiverFort Global Opportunities PCC Ltd (" RiverFort "), in accordance with the terms of the Facility as announced on 3 August 2023. The Company has an outstanding balance of circa £0.22 million under the Facility. Any balances pursuant to the Facility are not due for repayment until August 2025 (the " Maturity Date ") and the Company expects to settle all balances by the issuance of Subscription Shares prior to the Maturity Date. As noted in Sareum's announcement of 28 March 2024, the Company does not intend to make any further withdrawals pursuant to the Facility wi…
Issue of RiverFort Subscription Shares
the Company to RiverFort Global Opportunities PCC Ltd (" RiverFort "), in accordance with the terms of the Facility as announced on 3 August 2023. The Company has an outstanding balance of circa £0.64 million under the Facility. Any balances pursuant to the Facility are not due for repayment until August 2025 (the " Maturity Date ") and the Company expects to settle all balances by the issuance of Subscription Shares or by cash prior to the Maturity Date. As noted in Sareum's announcement of 28 March 2024, the Company does not intend to make any further withdrawals pursuant to the …
Issue of RiverFort Subscription Shares
the Company to RiverFort Global Opportunities PCC Ltd (" RiverFort "), in accordance with the terms of the Facility as announced on 3 August 2023. As announced on 3 August 2023, the Company entered into an Equity Prepayment Facility with RiverFort (the " Facility "). The Company has drawn £2.3 million to date pursuant to the Facility from two prepayment deposits. After this issue of 2.9m shares to RiverFort, the Company now has an outstanding balance of circa £0.8 million under the Facility. Any balances pursuant to the Facility are not due for repayment until August 2025 (the " Maturity…
Completion of Equity Fundraise
the Company has raised gross p roceeds of £1.17m through the issue of a total of 11,700,000 Fundraising Shares at the Placing Price, comprising 9,550,000 Placing Shares pursuant to the Placing by Hybridan LLP, 2,055,000 Subscription Shares pursuant to the Subscription by certain high net worth individuals and 195,000 new Ordinary Shares pursuant to the Director Subscription (of which 100,000 new Ordinary Shares were settled via the WRAP Retail Offer in respect of Dr Stephen Parker's subscription and 95,000 new Ordinary Shares are being issued via a direct subscription with the Company). …
Increase in size of WRAP Retail Offer
THIS ANNOUNCEMENT. THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE WRAP RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE UNITED KINGDOM FALLING WITHIN ARTICLE 43 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF THE SAREUM HOLDINGS PLC). ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE ENGAGED IN ONLY WITH SUCH PERSONS. THIS ANNOUNCEMENT…
Result of WRAP Retail Offer
THIS ANNOUNCEMENT. THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE WRAP RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE UNITED KINGDOM FALLING WITHIN ARTICLE 43 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF THE SAREUM HOLDINGS PLC). ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE ENGAGED IN ONLY WITH SUCH PERSONS. THIS ANNOUNCEMENT…
WRAP Retail Offer
THIS ANNOUNCEMENT. THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE WRAP RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE UNITED KINGDOM FALLING WITHIN ARTICLE 43 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF THE SAREUM HOLDINGS PLC). ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE ENGAGED IN ONLY WITH SUCH PERSONS. THIS ANNOUNCE…
Equity Fundraise
THIS ANNOUNCEMENT (INCLUDING THE APPENDICES) (THE " ANNOUNCEMENT ") AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, ITS STATES, TERRITORIES AND POSSESSIONS (" UNITED STATES "), AUSTRALIA, CANADA, JAPAN, SINGAPORE, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE PROHIBITED BY ANY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION TO BUY, S…
LinkedIn Activity
1Operations update: "Drilling of M3 Helium's next Fort Dodge well will commence in March 2026." AIM admission targeted for March 2026 with extension option to April 30, 2026. CEO: "March is expected to be a key period for operational and corporate progress." Compares Mendell's valuation to competitors (Pulsar Helium, Helix Exploration, Helium One).
PIR firm posting valuation comparisons to peer group -- potentially constitutes financial promotion by implying undervaluation. No risk warnings.
Board of Directors
13| Name | Role | Appointed | Status |
|---|---|---|---|
| Dr Stephen Barry Parker | Chief Executive Officer | 2016-05-17 | active |
| Clive Birch | Non-Executive Director | 2022-01-07 | active |
| Dr John Charles Reader | Executive Director | 2004-07-05 | active |
| Dr Michael Owen | Non-Executive Director | 2018-11-13 | active |
| Dr Timothy John Mitchell | Executive Director | 2004-07-05 | active |
| Anthony John Bunn | secretary | 2008-10-01 | active |
| John Taylor Stewart | secretary | 2004-07-05 | active |
| Ernesto Giorgio Reggiani | director | 2007-09-21 | active |
| Edward Morgan Oliver | director | 2004-07-05 | active |
| Dr Alastair James Riddell | director | 2007-11-15 | active |
| Paul Bernard Harper | director | 2004-08-01 | active |
| Dr Alan Gordon Lamont | director | 2004-09-08 | active |
| Dr David Hugh Williams | director | 2004-07-05 | active |